have constructed and produced a novel form of FasL protein which is chimeric with streptavidin (SA-FasL). We have engineered pancreatic islets using biotin as a bridge to display ... FasL chimeric protein on the surface…
hIgG, paired with either (hIgκ, ~500 μg/ml, fully human) or bovine (chimeric) light chain in plasma with a normal hIgG subclass distribution. Hyper-immunization with anthrax protective antigen resulted ... humoral…
this study was to produce chimeric bacterial protein conjugates, to separate them by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and study their reactivities with human serum immunoglobulins…
were transplanted with a very low CD3:CD34 cell ratio (0.1:1) a mix chimerism of huCD45+ T, B and myeloid cells was observed. To investigate whether a single ... cells. Instead, mice transplanted with human CD3+CD8+…
with non-MHC restricted (nor individual-specific) restricted recognition we have designed and engineered chimeric receptor whose antigen binding unit is made of single chain Fv of a given antibody ... domains of…
rare type of highly malignant, non-Hodgkin lymphoma (NHL). Currently, only studies on the chimeric oncogene NPM-ALK have reported a link to ALCL progression. However, the specific molecular mechanisms
hours after allo-HSCT) protected recipients from GvHD while preserving complete donor T cell chimerism and anti-viral immunity. The proliferation and activation of donor T cells, and serum ... native flagellin also…
involving supplementation of thiamine in the form of tablets manufactured from different wild and chimeric micro organisms that cannot reach all sections of society. In the present study, we attempt
Adoptive immunotherapy involving genetic modification of T cells with antigen-specific chimeric single-chain receptors is a promising approach for treatment of cancer. To determine whether gene-modified T cells…
fever in Angola and the Congo Democratic Republic. One hopes that the new tetravalent chimeric yellow fever-dengue vaccine will be of significant help in the fight against dengue fever ... world. The same applies to the…
have better efficacy and less toxicity as compared with agonistic antibodies, and generated a chimeric molecule where the extracellular functional domain of 4-1BBL fused C-terminus with ... innate, adaptive, and…
second part of the approach would be synthesized as chimeras. Th e chimeric peptide(s) will be expressed and purifi ed aft er cloning it into a suitable vector ... series / pET series). Th e chimeric peptides thus…
based vaccine formulations. To achieve this goal, we used ProtEx? for generation of chimeric SA-4-1BBL that exist as stable tetramers and higher structures, and as such ... specific. Vaccine was well tolerated and…
adult stages. Anx( Sm )3 was selected and engineered to be a recombinant chimeric peptide (rChimeric- AT) harbouring the linker region ... binding prediction showed that Anx(Sm)3 linker and Chimeric-AT were capable to…
adult stages. Anx( Sm )3 was selected and engineered to be a recombinant chimeric peptide (rChimeric- AT) harbouring the linker region ... binding prediction showed that Anx( Sm )3 linker and Chimeric-AT were capable to…
Recently, our research group demonstrated that a formulation containing the yPvCSP-AllCT chimeric protein, based on CSP from Plasmodium vivax (PvCSP), and the adjuvant Poly (I:C) (Invivogen) induced high
transplant-ineligible patients, and lenalidomide maintenance had moderate to high evidence. No reviews evaluated chimeric antigen receptor T-cell therapy or bispecific antibodies for NDMM. We identified five concerning…
ulcer disease, aseptic necrosis, diabetes mellitus and increased susceptibility to infections. Recently, rituximab, a chimeric anti-CD20 monoclonal antibody, which causes B-cell depletion, has been shown to improve…
effective in early stages, highlighting the need for novel and more effective therapeutic strategies. Chimeric antigen receptor (CAR) T-cell immunotherapies have demonstrated significant clinical efficacy, especially in…
been utilized, relapsed or refractory multiple myeloma (r/r MM) remains a critical challenge. Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a promising treatment
creation of monoclonal antibodies (mAbs), bispecific antibodies, antibody-drugconjugates (ADCs), and chimeric antigen receptor T-cell (CAR-T) therapies, all of which offer targeted approachesto treating complex…
Background: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized treatment for hematologic cancers by genetically modifying T-cells to target cancer antigens, providing hope for patients with relapsed
Cell therapy: This technique involves modifying a patient’s T cells to express Chimeric Antigen Receptors (CARs) that target cancer cells. CAR-T therapy has been particularly effective in treating
Chimeric Antigen Receptor (CAR) T-cell therapy is the modern tool in the armamentarium of hematologists to treat patients with several hematological malignancies. Although very effective for advanced disease
clinic. Bispecific antibodies and adoptive T cell transfer using immune cells modified to express chimeric antigen receptors have both recently received approvals for use in specific purposes. Bispecific antibodies link
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.